Neovision Capital

Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.

Dakang Medical operates a network of independent medical facilities specializing in blood purification services for kidney disease. The company focuses on providing advanced treatments such as hemodialysis, hemofiltration, and peritoneal dialysis, utilizing state-of-the-art medical technology. Dakang Medical emphasizes a patient-centered approach, aiming to create a warm and supportive environment to enhance the treatment experience for individuals suffering from nephropathy. In addition to its clinical services, Dakang Medical is involved in medical investment and the management of medical institutions, as well as offering brand operation services within the healthcare sector.

Xingsai Bio is a developer of single-cell analysis instruments and supporting reagents and consumables.

RzonTech is a provider of industrial software products, data services, and overall solutions.

Nuoyuan Medical is a developer of advanced medical devices that specializes in precision tumor surgery and treatment technology. The company's innovative products are designed to enhance clinical outcomes, optimize the use of medical resources, and increase the efficiency of healthcare professionals in oncology. By focusing on precision in surgical procedures, Nuoyuan Medical aims to improve patient care and outcomes in the treatment of tumors.

Matrixtime is an AI technology start-up. Based on deep learning, it is committed to the development of complex machine vision and industrial robot AI system products, empowering high-end manufacturing and providing scene-oriented industrial AI products. From high-end semiconductor manufacturing into complex machine vision inspection, Matrixtime has covered scenarios including advanced semiconductor manufacturing, photovoltaic energy, automotive precision manufacturing, and unmanned ports.

Xgene Pharmaceutical Inc. is a pharmaceutical company founded in 2015 and based in the Cayman Islands. The company specializes in the development of small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Through its research and development efforts, Xgene Pharmaceutical seeks to address significant medical needs in these areas.

Researcher and developer of cell therapy products intended to treat tumors and immune diseases. The company focuses on researching tumor infiltrating lymphocyte therapy (TIL) utilizing a combination of high-throughput gene sequencing (NGS) with CAR-T and other cutting-edge cell therapy technologies, enabling medical practitioners to perform more effective tumor diagnosis and treatment.

Shenzhen Andisec Co., Ltd. is an artificial intelligence company based in Beijing, China, specializing in industrial network security. The company focuses on the research and development of advanced technology, products, and services designed to enhance cybersecurity for industrial enterprises. Andisec's software is engineered to identify and defend against cyber attacks, viruses, and other security threats, enabling organizations to operate more securely in an increasingly digital landscape.

Rimag provides medical imaging service. The company engages in medical imaging center operation, relevant cloud technology development, and talent training. The company was founded in 2014 and is based in Shenzhen, China.

Shenzhen MicroApproach Medical Technology Co., Ltd. engages in research, development, manufacturing, and distribution of interventional surgery consumables. It offers endovascular medical devices, including hydrophyllic super-slippery guide wire, zebra guide wire, micro-guide wire, angiography catheter, guide catheter, and micro catheter. Shenzhen MicroApproach Medical Technology Co., Ltd was founded in 2015 and is based in Shenzhen, China.

Hangzhou Proprium Biotech Company Limited develops, manufactures, and sells biomedical products and diagnostic reagents for diagnosis of cancer and cardiovascular diseases. The company offers cardiac markers for diagnosis of heart diseases, such as NT-proBNP, D-Dimer, cTnI-HFABP, H-FABP, Myoglobin, cTnI, and CK-MB; cirrhosis markers for diagnosis of liver diseases, such as Fibro-CHI diagnostic kits; analyzers, such as proprium rapid immunoassay readers; and genetic testing equipment. It also offers colloidal gold rapid diagnostic kits, enzyme-linked immunosorbent assay (Elisa) rapid diagnostic kits, and polymerase chain reaction (PCR) rapid diagnosis detection kits. In addition, Hangzhou Proprium Biotech Company Limited develops a mobile application for liver diseases. The company was founded in 2010 and is based in Hangzhou, China.

Shanghai Allist Pharmaceuticals Co., Ltd. is a pharmaceutical company focused on the discovery, development, and commercialization of products aimed at improving human health. Established in 2004 and based in Shanghai, China, the company offers both generic and branded pharmaceuticals, specifically targeting treatments for cardiovascular diseases, acid-related disorders, and cancer. Allist Pharmaceuticals is recognized for its innovative approaches, particularly in the field of cancer treatment, and operates both domestically and internationally to expand its reach in the pharmaceutical market.

Shanghai Smartee Denti-Technology Co. Ltd is a company specializing in the development of an invisible orthodontic system, including a transparent aligner designed to move teeth into the desired position with precision. Founded in 2004 by a team of experts, including those with international experience and renowned orthodontics professionals, the company operates from the Shanghai Zhangjiang Hi-Tech Park. Smartee integrates advanced technologies such as 3D printing, computer-aided design (CAD), and digital modeling (CAM) to create aligners that are free from arch wires and brackets, making them safe for the oral cavity and easy to remove for eating and hygiene. The company collaborates with prominent research institutions, leveraging their expertise to enhance its digital orthodontic technology and has developed proprietary invisible appliance technology, which has received national accolades and patent protection for its innovative approach in orthodontics.

Beijing Biostar Technologies, Ltd. was incorporated in Haidian Park, Zhongguancun Science and Technology Park, Beijing, in July 2002. The national high-tech led by the team of Chinese scientists in the United States led by Dr. Tang Li and Dr. Qiu Rongguo. The company, focusing on biomedical development, technology and transfer of anti-tumor small molecule chemical drugs, and technical service consulting, pioneered the creation of new anti-cancer drugs for epothilone in China, and its technology is at the international advanced level.

Rimag provides medical imaging service. The company engages in medical imaging center operation, relevant cloud technology development, and talent training. The company was founded in 2014 and is based in Shenzhen, China.

ACROBiosystems Inc. manufactures recombinant oncological treatment proteins used in cancer immunotherapy. Its products include recombinant proteins, such as immune checkpoint proteins, targets of car-t cell therapy, biosimilar drug targets, fc receptor proteins, llama igg fc fusion protein, bio-markers and cd antigens, active max best cytokinesviral proteins, enzymes, antibodies, and other recombinant proteins; pre-labeled proteins, which includes biotinylated protein collection; and pre-labeled proteins, biotinylated protein collection, heavy-labeled products; kits, such as elisa assay kits for quantitative analysis of therapeutic antibodies in serum samples, inhibitor screening kits, and five-minute MAB iso typing kits. The company was founded in 2013 and is based in Newark, Delaware.

Oranger is a developer of portable wearable medical devices, focused on the treatment of medical-grade chronic respiratory diseases such as sleep apnea.

Shanghai Genext Medical Technology is a company based in Shanghai, China, specializing in the transplant industry. Founded in 2003, it develops and supplies transplantation drugs, medical devices, and in-vitro diagnostic tools. The company focuses on innovative technologies that enhance organ preservation and assessment, mechanical perfusion, and immunosuppression. Its product offerings include immunosuppressants, therapeutic drug monitoring equipment, and various operation accessories. Shanghai Genext Medical Technology supports a range of transplant procedures, including kidney, heart, lung, bone marrow, and cell transplants, aiming to provide reliable and cost-effective medical solutions for patients.

Boke Information Co., Ltd. is engaged in the research and development of management software, and providing management consultancy services in China. It also provides implementation and technology services relevant to management software products for various enterprises, government, and community organizations in China. It originally creates personalized products with the idea of autonomous configuration, self-expansion, and autonomous maintenance. It makes an IT deployment according to the whole life cycle for enterprises to help clients to build ecological organization chart and the whole lifecycle system framework.

RenRenChe, founded in April 2014, operates as a consumer-to-consumer (C2C) auto transaction service platform specializing in both used and new car sales. The company offers a range of services, including free door-to-door car valuation, sales, and replacement. To ensure quality, RenRenChe has established rigorous testing standards and employs a team of professional appraisers, collaborating with the China Automobile Dealers Association to set national benchmarks for second-hand car testing. The platform provides significant after-sales guarantees, including a 14-day return policy and a one-year warranty on core components, thereby enhancing buyer confidence. RenRenChe has attracted considerable investment, securing significant funding from notable investors, which has facilitated its growth and technological development within the industry.